Skip to content
10-Q

Quarterly Report

NANOVIRICIDES, INC. NNVC

0001104659-26-061499

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2026 · May 14, 2026 21.65M sh
Shares Diluted Q3 2026 · Mar 31, 2026 21.61M sh
Shares Diluted Q3 2026 · Mar 31, 2026 19.5M sh
Shares Diluted Q3 2026 · Mar 31, 2025 16.03M sh
Shares Diluted Q3 2026 · Mar 31, 2025 14.76M sh
Capex Q3 2026 · Mar 31, 2026 $84.32K
Capex Q3 2026 · Mar 31, 2025 $46.76K
Operating Cash Flow Q3 2026 · Mar 31, 2026 −$5.57M
Operating Cash Flow Q3 2026 · Mar 31, 2025 −$6.78M
Cash And Equivalents Q3 2026 · Mar 31, 2026 $3.21M
Cash And Equivalents Q3 2026 · Jun 30, 2025 $1.56M
Stockholders Equity Q3 2026 · Mar 31, 2026 $9.15M
Stockholders Equity Q3 2026 · Dec 31, 2025 $11.07M
Stockholders Equity Q3 2026 · Sep 30, 2025 $7.17M
Stockholders Equity Q3 2026 · Jun 30, 2025 $7.52M
Stockholders Equity Q3 2026 · Mar 31, 2025 $8.83M
Stockholders Equity Q3 2026 · Dec 31, 2024 $10.39M
Stockholders Equity Q3 2026 · Sep 30, 2024 $10.11M
Stockholders Equity Q3 2026 · Jun 30, 2024 $11.46M
Current Liabilities Q3 2026 · Mar 31, 2026 $1.07M
Current Liabilities Q3 2026 · Jun 30, 2025 $1.31M
Total Liabilities Q3 2026 · Mar 31, 2026 $1.1M
Current Assets Q3 2026 · Mar 31, 2026 $3.38M
Current Assets Q3 2026 · Jun 30, 2025 $1.67M
Total Assets Q3 2026 · Mar 31, 2026 $10.22M
Total Assets Q3 2026 · Jun 30, 2025 $8.82M
Eps Diluted Q3 2026 · Mar 31, 2026 −$0.09
Eps Diluted Q3 2026 · Mar 31, 2026 −$0.31
Eps Diluted Q3 2026 · Mar 31, 2025 −$0.14
Eps Diluted Q3 2026 · Mar 31, 2025 −$0.50
Eps Basic Q3 2026 · Mar 31, 2026 −$0.09
Eps Basic Q3 2026 · Mar 31, 2026 −$0.31
Eps Basic Q3 2026 · Mar 31, 2025 −$0.14
Eps Basic Q3 2026 · Mar 31, 2025 −$0.50
Sga Expense Q3 2026 · Mar 31, 2026 $744.28K
Sga Expense Q3 2026 · Mar 31, 2026 $2.66M
Sga Expense Q3 2026 · Mar 31, 2025 $966.91K
Sga Expense Q3 2026 · Mar 31, 2025 $3.1M
Rd Expense Q3 2026 · Mar 31, 2026 $1.29M
Rd Expense Q3 2026 · Mar 31, 2026 $3.4M
Rd Expense Q3 2026 · Mar 31, 2025 $1.28M
Rd Expense Q3 2026 · Mar 31, 2025 $4.37M
Net Income Q3 2026 · Mar 31, 2026 −$1.99M
Net Income Q3 2026 · Mar 31, 2026 −$6M
Net Income Q3 2026 · Dec 31, 2025 −$2.22M
Net Income Q3 2026 · Sep 30, 2025 −$1.79M
Net Income Q3 2026 · Mar 31, 2025 −$2.22M
Net Income Q3 2026 · Mar 31, 2025 −$7.37M
Net Income Q3 2026 · Dec 31, 2024 −$2.03M
Net Income Q3 2026 · Sep 30, 2024 −$3.13M
Operating Income Q3 2026 · Mar 31, 2026 −$2.03M
Operating Income Q3 2026 · Mar 31, 2026 −$6.06M
Operating Income Q3 2026 · Mar 31, 2025 −$2.25M
Operating Income Q3 2026 · Mar 31, 2025 −$7.48M